Furthermore, high EIF4EBP1 levels are associated with poor survival in all The Cancer Genome Atlas (TCGA) cancer entities combined [12], as well as in breast cancer [10, 11], colorectal cancer [13], hepatocellular carcinoma [14] or diffuse large B-cell lymphoma [15]. Here, EIF4EBP1 is linked to breast carcinoma.